[HTML][HTML] Clinical efficacy of Buzhong Yiqi decoction (补中益气汤) in the treatment of hospital-acquired pneumonia with multi-drug resistant bacteria: a prospective …

XU Xiangru, Z Yi, C Gang, LEI Ming… - Journal of Traditional …, 2023 - ncbi.nlm.nih.gov
OBJECTIVE To evaluate the efficacy and safety of Buzhong Yiqi decoction (补中益气汤,
BZYQ) in the treatment of hospital-acquired pneumonia (HAP) with multi-drug-resistant …

[HTML][HTML] Treatment of hospital-acquired pneumonia with multi-drug resistant organism by Buzhong Yiqi decoction based on Fuzheng Quxie classical prescription …

D Deng, Z Chen, L Jia, J Bu, M Ye, L Sun, Y Gen… - Trials, 2019 - Springer
Abstract Background Drug resistance in China is becoming a more and more serious issue.
Infection by drug-resistant bacteria has become a major disease that seriously threatens the …

Study on the efficacy and mechanism of Baihu Chengqi decoction in the treatment of severe pneumonia

W Min, YAN Lei - 2019 - sxzyxzz.com
摘 要 目的: 探讨白虎承气汤辅助治疗痰热壅肺证重症肺炎患者的疗效及作用机制. 方法: 选取
216 例痰热壅肺证型重症肺炎患者, 根据患者意愿纳入对照组和观察组. 对照组患者按西医重症 …

Effect of puji xuanfei xiaodu decoction as an alternative for antibiotics in treatment of community-acquired pneumonia: a multicenter double-blind randomized …

C Liu, G Yuan, SZ Ma, L Zhu, JL Yang, X Zhao… - 2020 - cabidigitallibrary.org
Objective: To observe the clinical efficacy of Chinese medicine (CM) Puji Xuanfei Xiaodu
Decoction (PXXD) to confirm whether it can be used as an alternative for antibiotics in the …

Clinical observation on therapeutic effect of Xiaoqinglong decoction for supplementary treatment of patients with ventilator associated pneumonia

H Zhu, J Kan, S Cao - … and Western Medicine in Intensive and …, 2016 - pesquisa.bvsalud.org
ObjectiveTo investigate the therapeutic effect of Xiaoqinglong decoction for supplementary
treatment of patients with ventilator-associated pneumonia (VAP). Methods Thirty-three VAP …

Efficacy and safety of the Qiguiyin formula in severe pneumonia: study protocol for a randomized, double-blind, placebo-controlled clinical trial.

H Po, G Yuhong, Z Jingxia, L Bo… - Journal of …, 2020 - search.ebscohost.com
OBJECTIVE: To evaluate the clinical efficacy and safety of Qiguiyin (QGY) formula in
patients with severe pneumonia in China compared with a placebo. METHODS: This is a …

[HTML][HTML] Clinical efficacy protocol of Yinhuapinggan Granules: A randomized, double-blind, parallel, and controlled clinical trial program for the intervention of …

J Wang, H Hu, H Du, M Luo, Y Cao, J Xu… - Frontiers in …, 2022 - frontiersin.org
Background: Community-acquired bacterial pneumonia (CABP) is an important health care
concern in the worldwide, and is associated with significant morbidity, mortality, and health …

Late-breaking abstract: intravenous infusion of Chinese medicine XueBiJing significantly improved clinical outcome in severe pneumonia patients in a multiple center …

Y Song, C Yao, H Shang, X Yao, C Bai - 2016 - Eur Respiratory Soc
Severe pneumonia (SP) is associated with high mortality and morbidity and increased
antibiotics resistance in the past decades further deteriorate its prognosis. Xuebijing, a …

Could Xuebijing Injection Reduce the Mortality of Severe Pneumonia Patients? A Systematic Review and Meta‐Analysis

J Wang, J Zhu, J Guo, Q Wang - … ‐Based Complementary and …, 2020 - Wiley Online Library
Background and Aim. Xuebijing injection (XBJ) is a Chinese traditional medicine
preparation, mainly made from Carthamus tinctorius flowers (Honghua in Chinese), Paeonia …

A clinical study on treatment of acute exacerbations of chronic bronchitis with Sangpa Zhike decoction

X Yan, J Cai, F You, L Zhang, C Lyu… - Chinese Journal of …, 2014 - pesquisa.bvsalud.org
Objective To observe the clinical effect of Sangpa Zhike decoction in the treatment of acute
exacerbations of chronic bronchitis. Methods 180 patients with acute exacerbation of chronic …